Related Experiment Video
Updated: May 13, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Impact of an Alert-Based Inpatient Clinical Decision Support Tool to Prevent Drug-Induced Long QT Syndrome:
Katy E Trinkley1, Steven T Simon2, Michael A Rosenberg2
1Adult and Child Center for Outcomes Research and Delivery Science Center, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Clinical decision support (CDS) tools effectively identified high-risk patients for drug-induced QT prolongation (diLQTS). However, alert-based systems did not reduce diLQTS risk or improve mortality outcomes.
Area of Science:
- Clinical Informatics
- Cardiology
- Pharmacology
Background:
- Clinical decision support (CDS) tools are integrated into electronic health records to alert clinicians about potential drug-induced QT prolongation (diLQTS).
- The effectiveness of these systems often relies on accurately identifying high-risk patients, but risk prediction alone may not guarantee improved outcomes.
Purpose of the Study:
- To evaluate the impact of a system-wide, alert-based inpatient CDS tool designed to prevent diLQTS.
- To assess the effect of the CDS tool across 10 known QT-prolonging medications on patient outcomes.
Main Methods:
- A comparative analysis of 178,097 hospitalizations (102,847 patients) before and after CDS implementation.
- Outcomes including diLQTS risk, hospitalization duration, and mortality were compared, with adjustments for patient demographics, comorbidities, and laboratory values.
Main Results:
- The CDS successfully identified high-risk patients for diLQTS (OR 2.28).
- No significant impact was observed on diLQTS risk or mortality based on provider responses to alerts.
- The overall risk of diLQTS did not significantly change post-implementation, while mortality rates increased.
Conclusions:
- Alert-based CDS systems, while effective at identifying high-risk patients for diLQTS, did not reduce the actual risk of diLQTS.
- System-wide implementation of CDS tools requires comprehensive evaluation beyond risk identification to ensure improved clinical outcomes.
More Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Desensitization and Tachyphylaxis
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...